xydalba
abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - antibakterijski lijekovi za sistemsku primjenu, - liječenje akutnih bakterijskih infekcija kože i strukture kože (absssi) u odraslih osoba.
ravicti
immedica pharma ab - glicerol fenilbutirat - poremećaji ciklusa ureje, umrli - drugi gastrointestinalni trakt i metabolizam, lijekovi, - ravicti prikazan na primjenu kao dodatna terapija za liječenje kroničnih bolesnika urea ciklusa poremećaja (ucds), uključujući nedostatke карбамоильную fosfat-sintaze-ja (sp), ornitin carbamoyltransferase (otn), argininosuccinate синтетазы (stražnjicu), argininosuccinate ЛиАЗы (АСЛ), аргиназы sam (aug) i ornitin translocase deficit hyperornithinaemia-hyperammonaemia homocitrullinuria sindrom (ННН), koje se ne može upravljati s hranom proteina ograničenje i/ili aminokiselinskih dodataka u miru. ravicti treba koristiti uz ograničenje proteina i, u nekim slučajevima, prehrambenih dodataka (e. , esencijalne aminokiseline, arginin, citrulin, dodatke bez kalorija bez proteina).
sulotrim 200 mg + 40 mg/5 ml oralna suspenzija
belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica - sulfamethoxazolum, trimethoprimum - oralna suspenzija - 200 mg + 40 mg/5 ml - urbroj: 5 ml oralne suspenzije sadrži 200 mg sulfametoksazola i 40 mg trimetoprima
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - ophthalmologicals - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastična sredstva - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
aqumeldi
proveca pharma limited - enalapril (maleate) - zastoj srca - sredstva koja djeluju na sustav renin-angiotenzina - treatment of heart failure.
uebe visomat comfort form
društvo za proizvodnju, promet i usluge, export - import "meditas" d.o.o podgorica - elektro-mehanička medicinska sredstva
uebe visomat medic pro
društvo za proizvodnju, promet i usluge, export - import "meditas" d.o.o podgorica - elektro-mehanička medicinska sredstva
uebe visomat stethoscope pro
društvo za proizvodnju, promet i usluge, export - import "meditas" d.o.o podgorica - medicinska sredstva za višekratnu upotrebu
glukognost visual test trake
biognost d.o.o., zagreb - test trake za određivanje glukoze u perifernoj krvi